Related Experiment Video
Updated: Mar 17, 2026

10:21
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
945
Castleman's Disease and Interleukin 6
1a Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
Leukemia & Lymphoma
|July 27, 2016
Summary
Castleman's disease involves benign lymph node growths. Overproduction of Interleukin-6 (IL-6) by these nodes likely causes the disease's symptoms, suggesting it's an IL-6 production disorder.
Area of Science:
- Immunology
- Pathophysiology
- Rare Diseases
Background:
- Castleman's disease presents as benign hyperplastic lymph nodes.
- Hyaline-vascular, plasma cell, and intermediate types exist.
- Plasma cell and intermediate types link to fever, anemia, and elevated C-reactive protein (CRP).
Purpose of the Study:
- Investigate the underlying mechanisms of Castleman's disease clinical manifestations.
- Clarify the role of immunological disturbances in the disease's pathophysiology.
- Determine the specific cytokine responsible for the observed clinical features.
Main Methods:
- Reported a pediatric case of Castleman's disease.
- Assessed B cell differentiation factor (BCDF) activity in hyperplastic lymph nodes.
- Examined lymph node cells for Interleukin-6 (IL-6) gene expression.
Main Results:
- Demonstrated spontaneous high levels of B cell differentiation factor (BCDF) activity.
- Confirmed strong expression of the Interleukin-6 (IL-6) gene in lymph node cells.
- IL-6 is a multifunctional cytokine inducing immunoglobulin production, acute phase reactions, and acting as an endogenous pyrogen.
Conclusions:
- Overproduction of IL-6 by hyperplastic lymph nodes is strongly linked to Castleman's disease pathophysiology.
- IL-6 may induce CRP increase and hypotransferrinemia during acute phase reactions.
- Castleman's disease is proposed to be a disorder of IL-6 production.
Related Concept Videos
The JAK-STAT Signaling Pathway
13.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.7K
T Cell Types and Functions
3.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
709
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
709
Inflammatory Bowel Disease II: Crohn's Disease
1.5K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K

